This workshop session will provide a major update regarding old and new challenges for managing anaphylaxis
LEARNING OBJECTIVES:
Upon completion of this activity, participants should be able to:
- Discuss challenges of managing anaphylaxis in public spaces such as schools, restaurants, airplanes, hospitals, and areas affected by epinephrine shortages
- Discuss anaphylaxis risk with new treatments from immunotherapy to biologics
- Discuss anaphylaxis risk in primary mast cell disorders
Moderator Introduction
Anil Nanda, MD FAAAAI
Asthma and Allergy Center
Current Challenges in Managing Anaphylaxis in Public Spaces in an Increasingly Mobile Society
Julie Wang, MD FAAAAI
Icahn School of Medicine at Mount Sinai
Risk of Anaphylaxis in the Era of Immunomodulation: Risks and Benefits of Novel Therapies
Antonella Cianferoni, MD PhD FAAAAI
Children's Hospital of Philadelphia
Risk of Anaphylaxis When Mast Cells Go Wild
Olajumoke Fadugba, MD
University of Pennsylvania
Please take a moment to click the link below and give us your feedback on this session:
